Abingdon Health PLC Change of Nominated Adviser and Sole Broker
May 08 2024 - 2:00AM
RNS Regulatory News
RNS Number : 5053N
Abingdon Health PLC
08 May 2024
Abingdon
Health plc
("Abingdon Health" or "the Company")
Change of
Nominated Adviser and Sole Broker
Abingdon Health plc is pleased to
announce the appointment of WH Ireland Limited as the Company's
Nominated Adviser and Sole Broker, with immediate
effect.
Enquiries
|
Abingdon Health plc
|
www.abingdonhealth.com/investors/
|
|
Chris Yates, Chief Executive
Officer
|
|
|
Chris Hand, Non-Executive
Chairman
|
|
|
WH
Ireland Limited (Sole Broker and Nominated
Adviser)
|
Tel: +44 (0) 20 7220 1666
|
|
Chris Fielding / Isaac
Hooper (Corporate Finance)
|
|
|
Fraser Marshall (Corporate
Broking)
|
|
About Abingdon Health plc
Abingdon Health is a leading
lateral flow contract development and manufacturing organisation
("CDMO") offering its services to an international customer base
across industry sectors that include clinical, animal health, plant
health, and environmental testing. Abingdon Health has the internal
capabilities to take projects from initial concept through to
routine and large-scale manufacturing; from "idea to commercial
success."
The Company's CDMO division offers
product development, regulatory support, technology transfer and
manufacturing services for customers looking to develop new assays
or transfer existing laboratory-based assays to a lateral flow
format. Abingdon Health aims to support the increase in
need for rapid results across many industries and locations and
produces lateral flow tests in areas such as infectious disease,
clinical testing including companion diagnostics, animal health and
environmental testing. Faster access to results allows for rapid
decision making, targeted intervention and can support better
outcomes.
Abingdon Health's Abingdon Simply
Test range of self-tests is an ecommerce platform that offers a
range of self-tests to empower consumers to manage their own health
and wellbeing. The Abingdon Simply
Test ecommerce site offers consumers a range of information to
support them in making informed decisions on the tests available.
In addition, the site provides Abingdon's contract services
customers with a potential route to market for self-tests. The
Abingdon Simply Test range is also sold through international
distributors and through other channels in the UK and Ireland such
as pharmacy chains.
Founded in 2008, Abingdon
Health is headquartered in York, England.
For more information
visit: www.abingdonhealth.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
APPQKOBPFBKDBPK
Abingdon Health (LSE:ABDX)
Historical Stock Chart
From Jan 2025 to Feb 2025
Abingdon Health (LSE:ABDX)
Historical Stock Chart
From Feb 2024 to Feb 2025
